
Contact us
About company
angioClast is a Cambridge biotech startup comitted to transform cancer research. Through the application of de novo markers of cancer blood vessels, angioClast strives to develop and revolutionize the treatment and diagnosis of various cancer types.
Unknown
Unknown
Not verified company